N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide

C39H67N5O8S — CID 143801100

IUPACN-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide
SMILESCCOCC(C)(C)S(=O)(=O)CC1(NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3CC(C(C)C)CN3C2=O)CCCCC1
InChIInChI=1S/C39H67N5O8S/c1-6-52-25-38(4,5)53(50,51)26-39(21-15-12-16-22-39)43-37(49)42-31-18-14-11-9-7-8-10-13-17-30(33(45)35(47)40-29-19-20-29)41-34(46)32-23-28(27(2)3)24-44(32)36(31)48/h27-32H,6-26H2,1-5H3,(H,40,47)(H,41,46)(H2,42,43,49)/t28?,30-,31-,32-/m0/s1
InChIKeyARBKSSDHMLHVEO-BFJKATCTSA-N
MW766.06 g/mol
LogP4.32
Rot. Bonds12

About N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide

N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide (PubChem CID 143801100) has the molecular formula C39H67N5O8S and a molecular weight of 766.06 g/mol. Its IUPAC name is N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide.

Molecular Properties

Compound NameN-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide
PubChem CID143801100
Molecular FormulaC39H67N5O8S
Molecular Weight766.06 g/mol
Exact Mass765.47
IUPAC NameN-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide
SMILESCCOCC(C)(C)S(=O)(=O)CC1(NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3CC(C(C)C)CN3C2=O)CCCCC1
InChIInChI=1S/C39H67N5O8S/c1-6-52-25-38(4,5)53(50,51)26-39(21-15-12-16-22-39)43-37(49)42-31-18-14-11-9-7-8-10-13-17-30(33(45)35(47)40-29-19-20-29)41-34(46)32-23-28(27(2)3)24-44(32)36(31)48/h27-32H,6-26H2,1-5H3,(H,40,47)(H,41,46)(H2,42,43,49)/t28?,30-,31-,32-/m0/s1
InChIKeyARBKSSDHMLHVEO-BFJKATCTSA-N
XLogP4.32
TPSA180.08 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds12
Heavy Atoms53
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500766.06
LogP ≤ 54.32
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide?
The IUPAC name of N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide (CID 143801100) is N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide.
What is the SMILES notation for N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide?
The canonical SMILES for N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide is CCOCC(C)(C)S(=O)(=O)CC1(NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3CC(C(C)C)CN3C2=O)CCCCC1.
What is the InChIKey of N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide?
The InChIKey is ARBKSSDHMLHVEO-BFJKATCTSA-N. The full InChI is InChI=1S/C39H67N5O8S/c1-6-52-25-38(4,5)53(50,51)26-39(21-15-12-16-22-39)43-37(49)42-31-18-14-11-9-7-8-10-13-17-30(33(45)35(47)40-29-19-20-29)41-34(46)32-23-28(27(2)3)24-44(32)36(31)48/h27-32H,6-26H2,1-5H3,(H,40,47)(H,41,46)(H2,42,43,49)/t28?,30-,31-,32-/m0/s1.
What are the key properties of N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide?
N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide has a molecular weight of 766.06 g/mol, XLogP of 4.32, 12 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-cyclopropyl-2-[(3S,13S,16S)-3-[[1-[(1-ethoxy-2-methylpropan-2-yl)sulfonylmethyl]cyclohexyl]carbamoylamino]-2,15-dioxo-18-propan-2-yl-1,14-diazabicyclo[14.3.0]nonadecan-13-yl]-2-oxoacetamide is sourced from PubChem (CID 143801100), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).